Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease

European Journal of Vascular and Endovascular Surgery

Volumn 29, Issue 2, 2005, Pages 171-176

  Cassar, K ^a,b   Bachoo, P ^b   Ford, I ^a   Greaves, M ^a   Brittenden, J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Haemostasis; Peripheral arterial disease; Thrombosis and vascular biology

Indexed keywords

C REACTIVE PROTEIN; D DIMER; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; VON WILLEBRAND FACTOR;

EID: 12144270354     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2004.11.001     Document Type: Article

References (34)

1. M.H. Criqui A. Fronek E. Barrett-Connor M.R. Klauber S. Gabriel D. Goodman The prevalence of peripheral arterial disease in a defined population Circulation 71 1985 510-515
2. J. Dormandy L. Heeck S. Vig The natural history of claudication: Risk to life and limb Semin Vasc Surg 12 1999 123-137
3. G.C. Leng A.J. Lee F.G. Fowkes M. Whiteman J. Dunbar E. Housley C.V. Ruckley Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral artery disease in the general population Int J Epidemiol 24 1996 1172-1181
4. R. Ross J.A. Glomset The pathogenesis of atherosclerosis (Part I) NEJM 295 1976 369-375
5. R. Ross J.A. Glomset The pathogenesis of atherosclerosis (Part II) NEJM 295 1976 420-425
6. K. Cassar P. Bachoo J. Brittenden The role of platelets in peripheral vascular disease Eur J Vasc Endovasc Surg 25 2003 6-15
7. J.H. Chesebro U. Rauch V. Fuster J.J. Badimon Pathogenesis of thrombosis in coronary artery disease Haemostasis 27 Suppl 1 1997 12-18
8. K. Cassar P. Bachoo I. Ford M. Greaves J. Brittenden Platelet activation is increased in peripheral arterial disease J Vasc Surg 25 2003 6-15
9. P.A. Robless D. Okonko P. Lintott A.O. Mansfield D.P. Mikhailidis G.P. Stansby Increased platelet aggregation and activation in peripheral arterial disease Eur J Vasc Endovasc Surg 25 2003 16-22
10. C.B. Reininger J. Graf A.J. Reininger M. Spannagl B. Steckmeier L. Schweiberer Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease Thromb Res 82 1996 523-532
11. A. Strano D. Hoppensteadt J.M. Walenga J. Fareed C. Sabba E. Berardi C. Allegra A. Carlizza F. Binaghi F. Fronteddu R. Del Guercio M. Del Guercio A. Pinto G. Alletto M. Nazzari P.A. Ferrari Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease Semin Thromb Hemost 22 Suppl 1 1996 35-40
12. A. Trifiletti N. Barbera M.A. Pizzoleo S. Lucifora S. Soraci R. Scamardi M. Pedulla N. Frisina Hemostatic disorders associated with arterial hypertension and peripheral arterial disease J Cardiovasc Surg 36 1995 483-485
13. J.G. van der Bom M.L. Bots F. Haverkate P. Meijer A. Hofman C. Kluft D.E. Grobbee Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease Thromb Haemost 85 2001 234-239
14. T. Herren H. Stricker A. Haeberli D.D. Do P.W. Straub Fibrin formation and degradation in patients with arteriosclerotic disease Circulation 90 1994 2679-2686
15. F.B. Smith A.J. Lee C.M. Hau A. Rumley G.D. Lowe F.G. Fowkes Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh artery study Blood Coagul Fibrinolysis 11 2000 43-50
16. Antithrombotic Trialists' Group Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients BMJ 324 2002 71-86
17. P.E. Short C.E. Williams A.M. Picken F.G.H. Mill Factor VIII related antigen: An improved enzyme immunoassay Med Lab Sci 39 1982 351-355
18. M.M. McDermott D. Green P. Greenland et al. Relation of levels of haemostatic factors and inflammatory markers to the ankle brachial index Am J Cardiol 92 2003 194-199
19. P.M. Ridker N. Rifai M.A. Pfeffer Novel risk factors for systemic atherosclerosis; A comparison of CRP, fibrinogen, homocysteine, lipoprotein A, and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481-2485
20. D.L. Bhatt E.J. Topez Need to test the arterial inflammation hypothesis Circulation 106 2002 136-4019
21. P.M. Ridker N. Rifai L. Rose J.E. Buring N.R. Cook Comparison of CRP and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557-1565
22. K. Cassar R. Coull P. Bachoo E. Macaulay J. Brittenden Primary care risk factor management in Claudicants Eur J Vasc Endovasc Surg 26 2003 145-149
23. A.D. Blann T. Naqvi M. Waite C.N. McCollum Von Willebrand factor and endothelial damage in essential hypertension J Hum Hypertens 7 1993 107-111
24. M. Greaves R.G. Malia K. Goodfellow M. Mattock L.K. Stevens J.M. Stephenson J.H. Fuller Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study Diabetologia 40 6 1997 698-705
25. A.D. Blann The acute influence of smoking on the endothelium Atherosclerosis 96 1992 249-250
26. R.A. Kadir D.L. Economides C.A. Sabin D. Owens C.A. Lee Variations in coagulation factors in women: Effect of age, ethinicity, menstrual cycle and combined oral contraceptive Thromb Haemost 82 1999 1456-1461
27. W.L. Hutchinson W. Koenig M. Frohlich M. Sund G.D. Lowe M.B. Pepys Immunoradiometric assay of circulating C-reactive protein: Age related values in the adult general poulation Clin Chem 46 2000 934-938
28. C.B. Reininger J. Graf A.J. Reininger M. Spannagl B. Steckmeier L. Schweiberer Increased platelet and coagulatory activity in peripheral atherosclerosis: Flow mediated platelet function is a sensitive and specific disease indicator Int Angiol 15 4 1996 335-343
29. S. Kamath A.D. Blann B.S. Chin F. Lanza B. Aleil J.P. Cazenave G.Y. Lip A study of platelet activation in atrial fibrillation and the effects of antithrombotic, therapy Eur Heart J 23 22 2002 1788-1795
30. T. Yasu S. Oshima M. Imanishi H. Nonogi K. Haze M. Kuramochi T. Omae Y. Hayashi S. Yamamoto Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris Am J Cardiol 71 13 1993 1164-1168
31. H. Tohgi H. Takahashi K. Chiba K. Tamura Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication Stroke 24 6 1993 801-804
32. Peripheral Arterial Disease Antiplatelet Consensus Group Antiplatelet therapy in peripheral arterial disease. Consensus statement Eur J Vasc Endovasc Surg 26 2003 1-16
33. S. Peltonen R. Lassila J. Heikkila Activation of coagulation and fibrinolysis despite heparinisation during successful elective coronary angioplasty Thromb Res 82 1996 459-468
34. S. Suzuki T. Matsuo H. Kobayashi M. Matsuo C. Shimamo M. Koide S. Sakamoto Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: Effects on inflammatory, hemostatic, and endothelium-derived parameters Thromb Res 98 2000 269-279